68308-220 : Esgic Oral Tablet


NDC68308-220
Labeler: Midlothian Laboratories
Product Type: Human Prescription Drug
Drug Name:  Esgic
Dosage Form: Oral Tablet
Application #: ANDA089175
Rev. Date: 
CSA Schedule: CIII (US) [1]


[1] Schedule III / IIIN Controlled Substance: Has a potential for abuse less than substances in Schedules I or II and abuse may lead to moderate or low physical dependence or high psychological dependence. (i.e. Products containing not more than 90 milligrams of Codeine per dosage unit [such as Tylenol with Codeine], other narcotics such as Buprenorphine (Suboxone), and Schedule IIIN non-narcotics such as Didrex, Ketamine, Phendimetrazine, and Anabolic Steroids). More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: 535;11
Shapes:  Oval
Colors:  White
Size (mm): 14
Segments: * 2

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces.

NDC Package Codes:

  • 68308-220-01: 100 TABLET IN 1 BOTTLE, PLASTIC (68308‑220‑01)

Active Ingredients:

  • Acetaminophen
  • Butalbital
  • Caffeine

Dosage Strength:

  • 325 mg
  • 50 mg
  • 40 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Croscarmellose Sodium
  • Crospovidone
  • Povidones
  • Silicon Dioxide
  • Starch, Corn
  • Stearic Acid

Pharmaceutical Classes:

  • Barbiturate [EPC]
  • Barbiturates [Chemical/Ingredient]
  • Central Nervous System Stimulant [EPC]
  • Central Nervous System Stimulation [PE]
  • Methylxanthine [EPC]
  • Xanthines [Chemical/Ingredient]

Related Products:

Based on records with the same trade name.
  • 68308-219 Esgic Oral Capsule by Midlothian Laboratories
  • 0535-0011 Esgic (Apap 325 mg / Butalbital 50 mg / Caffeine 40 mg) Oral Tablet by Forest Laboratories, Inc.
  • 0535-0012 Esgic (Apap 325 mg / Butalbital 50 mg / Caffeine 40 mg) Oral Capsule by Forest Laboratories, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68308-220 QR Code

< Prev: 68308-219Next: 68308-221 >

Related Discussions:

butalbital acetaminophen caffeine 50/325/40 uses
How long does it take for the pain from a bad migraine to go away? I've been taking the pills for 3 days and I still... 7 replies
butalbital acetaminophen caffeine and codeine
blue and tan capsule westward 3000 ## This is a generic version of Fiorcet, most often used for severe headaches and mig... 3 replies
butalbital + acetaminophen + caffeine 50/325/40
There is no label on my butalbital + acetaminophen + caffeine. What is it used for? And is it a narcotic? ## Hello, Patr... 1 reply
Acetaminophen 325mg + Butalbital 50mg + Caffeine 40mg availability
I would like to know if these are available online, either in the UI, SA, A, or Canada..? Any information, address, tele... 2 replies
Effects of Alcohol with Butalbital Acetaminophen Caffeine 50-325-40
I have taken 3 doses of Butalbital Acetaminophen Caffeine (50-325-40) within the last 9 hours. My last one being an hour... 1 reply
is hydroco/apap 5-325 mg stronger than BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE tablets
is hydroco/apap 5-325 mg stronger than BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE tablets i have BUTALBITAL, ACETA... 3 replies
are butalbital acetaminophen caff tabs the same asbut apap caf codeine
Are these two the same? One says butalbital/acetaminophen/caff tabs the other says but/apap/caf codeine the first one in... 2 replies
Allzital (Butalbital 25mg / Acetaminophen 325mg)
Are these for headache treatment? I need to know if I could take it if I'm already taking two Norco 10/325mg tablets... 1 reply
Caffeine and acetaminophen
I suffer from Hypnic headaches and the only thing that keeps my from waking up with a headache every morning is to take ... 2 replies
500mg Acetaminophen 65mg Caffeine
I have taken aspirin free excedrin for headaches for years,. Now that is off the market I have tried similar generic bra... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.